Iohexol
Overview
Iohexol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200455).
API suppliers (5)
Suppliers of Iohexol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 5 suppliers.
1 of 5 holds a GMP certificate on record in the EU or UK registers
- Zhejiang Starry Pharmaceutical Co., LtdChina1 active DMF
- Zhejiang Haizhou Pharmaceutical Co., Ltd.China1 active DMF
- DIVI'S LABOTATORIES LTD1 active DMF
- SUZHOU RYWAY BIOTECH CO LTD1 active DMF
- Hovione FarmaCiencia SAPortugal GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (11 approved US products), the latest listed US patent on Iohexol expires — and exclusivity 26 Jul 2026. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
- Canonical SMILES
- CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
- InChIKey
- NTHXOOBQLCIOLC-UHFFFAOYSA-N
Do you supply Iohexol? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.